Pioneering Medical and Genetic Research

Autoimmune diseases are currently diagnosed by ruling out other possibilities, meaning there is no definitive test that can be performed to quickly and accurately determine what disease is involved. This leads to years of debilitating symptoms and declining health for patients in desperate need of answers. In addition, medications are not developed if diseases are not properly diagnosed.

 

At Strata we believe that the foundation to restoring health always begins with an efficient and correct diagnosis. Which is why we are on the forefront of developing non-invasive, pinpoint diagnostic tools.

Understanding what form of a disease we have can play a pivotal role in proper treatment. Defining whether a disease is caused by a change in DNA, is acquired during a patient's lifetime or involves a combination of both inherited and environmental factors is crucial to understanding their specific needs. If this is inherited via a change at the DNA level, lifestyle changes are not likely to provide relief of symptoms and medication will often be necessary. Whereas if someone inhaled a toxin and their body responded inappropriately by staying “ON” after the threat was over, there may be instances where lifestyle & short term treatment can bring the body back into alignment. 

 

In addition to providing the best outcome possible for patients, we also understand the value that knowing the origin of disease brings. This is why Strata places a strong emphasis on finding any genetic markers that correspond to a particular disorder.

Treating symptoms should never be considered a fix to a patient’s health problems.  Operating in this way can lead to unwanted side effects and be an ineffective way to manage a disease in the long term. We also must take into account someone’s quality of life and suppressing the entire immune system can severely limit their access to much needed community and family activities.

Likewise, prescribing pain pills instead of treating the cause of the pain only masks what’s happening to a patient’s body.

 

It’s only when we can diagnose exactly what a patient has and how they came to have it that can we choose the appropriate medication to meet their needs and give them their health back. This is why Strata has been instrumental in championing novel medications for known diseases.